Literature DB >> 15616840

Role of quinine in life-threatening Babesia divergens infection successfully treated with clindamycin.

C Corpelet1, P Vacher, F Coudore, H Laurichesse, N Conort, B Souweine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616840     DOI: 10.1007/s10096-004-1270-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Management of Babesia divergens babesiosis without a complete course of quinine treatment.

Authors:  E Denes; J P Rogez; M L Dardé; P Weinbreck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-09       Impact factor: 3.267

2.  Acute babesiosis caused by Babesia divergens in a resident of Kentucky.

Authors:  James F Beattie; Marie L Michelson; Patricia J Holman
Journal:  N Engl J Med       Date:  2002-08-29       Impact factor: 91.245

3.  In vitro evaluation of drug susceptibilities of Babesia divergens isolates.

Authors:  P Brasseur; S Lecoublet; N Kapel; L Favennec; J J Ballet
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Quinine in the treatment of Babesia divergens infections in humans.

Authors:  P Brasseur; S Lecoublet; N Kapel; L Favennec; J J Ballet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

5.  Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination.

Authors:  D N Bateman; P G Blain; K W Woodhouse; M D Rawlins; H Dyson; R Heyworth; L F Prescott; A T Proudfoot
Journal:  Q J Med       Date:  1985-02

Review 6.  Babesiosis.

Authors:  M J Homer; I Aguilar-Delfin; S R Telford; P J Krause; D H Persing
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

  6 in total
  4 in total

Review 1.  [Parasitic diseases of the central nervous system].

Authors:  E Schmutzhard
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 2.  Human babesiosis in Europe: what clinicians need to know.

Authors:  A Hildebrandt; J S Gray; K-P Hunfeld
Journal:  Infection       Date:  2013-10-09       Impact factor: 7.455

3.  Severe babesiosis in immunocompetent man, Spain, 2011.

Authors:  Luis M Gonzalez; Susana Rojo; Fernando Gonzalez-Camacho; Daniel Luque; Cheryl A Lobo; Estrella Montero
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

Review 4.  Pulmonary complications of babesiosis: case report and literature review.

Authors:  B A Cunha; S Nausheen; D Szalda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-07       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.